GlaxoSmithKline 2Q Net Profit Drops Despite Higher Sales; Backs 2021 Outlook
July 28 2021 - 6:39AM
Dow Jones News
By Cecilia Butini
GlaxoSmithKline PLC said Wednesday that net profit dropped in
the second quarter compared with the previous year, though sales
grew on-year and it backed its outlook for the full year.
The British pharmaceutical major posted net profit of 1.40
billion pounds ($1.94 billion) for the period, down from GBP2.26
billion the year prior. Adjusted earnings per share were 28.1
pence, compared with 19.2 pence in the same period a year
earlier.
Sales came in at GBP8.09 billion, up from GBP7.62 billion in the
second quarter of 2020, when both pharmaceuticals and vaccine sales
were affected by the pandemic.
The company backed a previously given outlook for 2021, saying
that it expects adjusted EPS to decline by mid-to-high single-digit
percentage at constant exchange rates. Looking at 2022, it said it
expects meaningful improvements in revenues and margins.
GlaxoSmithKline declared a dividend of 19 pence a share for the
second quarter, adding that it continues to expect a dividend of 80
pence a share for the full year 2021.
Write to Cecilia Butini at cecilia.butini@wsj.com
(END) Dow Jones Newswires
July 28, 2021 07:39 ET (11:39 GMT)
Copyright (c) 2021 Dow Jones & Company, Inc.
Gsk (LSE:GSK)
Historical Stock Chart
From Mar 2024 to Apr 2024
Gsk (LSE:GSK)
Historical Stock Chart
From Apr 2023 to Apr 2024